Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumococcal infections - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. see sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes.the use of vaxneuvance should be in accordance with official recommendations.

Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - periciazine, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; wheat starch; magnesium stearate; colloidal anhydrous silica - severe anxiety and tension states and the maintenance treatment of the psychotic patient. it is useful in controlling such symptoms as impulsiveness and aggression.

Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

life molecular imaging gmbh - florbetaben (18f) - radionuclide imaging; alzheimer disease - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.neuraceq is a radiopharmaceutical indicated for positron emission tomography (pet) imaging of β amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for alzheimer’s disease (ad) and other causes of cognitive impairment. neuraceq should be used in conjunction with a clinical evaluation.a negative scan indicates sparse or no plaques, which is not consistent with a diagnosis of ad.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

lantheus medical imaging, inc. - bicisate dihydrochloride (unii: b005p07v07) (bicisate - unii:3jxf0z0xoi) - bicisate dihydrochloride 0.9 mg - neurolite single photon emission computerized tomography (spect) is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed. neurolite is not indicated for assessment of functional viability of brain tissue. also, neurolite is not indicated for distinguishing between stroke and other brain lesions. none known.

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - clostridium botulinum toxin type a -

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

clinect nz pty limited - periciazine 10mg;  ;   - tablet - 10 mg - active: periciazine 10mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose wheat starch - in adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. in anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. neulactil is used as an adjunct to the short-term management of these conditions.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

clinect nz pty limited - periciazine 2.5mg;  ;   - tablet - 2.5 mg - active: periciazine 2.5mg     excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose wheat starch - in adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. in anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. neulactil is used as an adjunct to the short-term management of these conditions.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - bicisate dihydrochloride, quantity: 0.9 mg - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; water for injections - [99mtc]-bicisate scintigraphy is indicated in the evaluation and localisation of regional perfusion abnormalities in adult patients with the central nervous system disorders of stroke and dementia.

Ισραήλ - Αγγλικά - Ministry of Health

medison pharma ltd - cerliponase alfa - solution for infusion - cerliponase alfa 30 mg / 1 ml - cerliponase alfa - brineura is indicated for the treatment of patients with neuronal ceroid lipofuscinosis type 2 (cln2) disease, also known as tripeptidyl peptidase 1 (tpp1) deficiency.